OPTUS Pharmaceutical Co., Ltd. Logo

OPTUS Pharmaceutical Co., Ltd.

Develops and manufactures ophthalmic solutions for dry eye, infections, and inflammation.

131030 | KO

Overview

Corporate Details

ISIN(s):
KR7131030009
LEI:
Country:
South Korea
Address:
충청북도 청주시 흥덕구 오송읍 오송생명6로 50, 청주시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

OPTUS Pharmaceutical Co., Ltd. (formerly DHP Korea Co Ltd) is a specialized pharmaceutical company dedicated to providing total eye care solutions. The company develops, manufactures, and markets a comprehensive portfolio of ophthalmic products targeting conditions such as dry eye syndrome, bacterial infections, and inflammation. Its product line includes preservative-free artificial tears and medicated eye drops with active ingredients like sodium hyaluronate, cyclosporine, and moxifloxacin. OPTUS Pharmaceutical operates a dedicated, GMP-compliant manufacturing plant that specializes in producing single-dose ophthalmic preparations, ensuring high standards of safety and quality. The company is committed to continuous research and innovation in eye health and also provides contract manufacturing services.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 994.7 KB
2025-07-09 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 64.5 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 898.2 KB
2025-04-15 00:00
Transaction in Own Shares
자기주식처분결과보고서
Korean 17.0 KB
2025-04-09 00:00
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
Korean 30.2 KB
2025-03-25 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 33.7 KB
2025-03-25 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 18.4 KB
2025-03-25 00:00
Board/Management Information
대표이사변경
Korean 9.1 KB
2025-03-17 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.1 MB
2025-03-13 00:00
Audit Report / Information
감사보고서제출
Korean 17.6 KB
2025-03-10 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 135.1 KB
2025-03-10 00:00
Proxy Solicitation & Information Statement
[기재정정]의결권대리행사권유참고서류
Korean 126.7 KB
2025-03-07 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 19.1 KB
2025-03-07 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 120.2 KB
2025-03-07 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 111.4 KB

Automate Your Workflow. Get a real-time feed of all OPTUS Pharmaceutical Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for OPTUS Pharmaceutical Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for OPTUS Pharmaceutical Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Eurobio Scientific Logo
Develops & distributes specialty IVD tests for oncology, transplant & infectious diseases.
France
ALERS
European Institute of Science AB Logo
Manufactures diagnostic assays and point-of-care instruments for the veterinary health market.
Sweden
EURI B
Evoke Pharma Inc Logo
Develops and commercializes a nasal spray for diabetic gastroparesis symptom relief.
United States of America
EVOK
Evolus, Inc. Logo
Develops neurotoxins and dermal fillers for the medical aesthetics market.
United States of America
EOLS
EXACT SCIENCES CORP Logo
Provides advanced cancer screening and diagnostic tests for early detection and treatment guidance.
United States of America
EXAS
EXELIXIS, INC. Logo
An oncology-focused biotech that discovers and develops medicines for hard-to-treat cancers.
United States of America
EXEL
EXICURE, INC. Logo
Develops nucleic acid therapies via its SNA™ platform for neurology, oncology, & genetic diseases.
United States of America
XCUR
ExpreS2ion Biotech Holding AB Logo
Clinical-stage biotech developing vaccines and immunotherapies via a proprietary protein platform.
Sweden
EXPRS2
EyeGene,Inc Logo
Develops gene/cell therapies & mRNA vaccines for age-related and ocular diseases.
South Korea
185490
EyePoint Pharmaceuticals, Inc. Logo
Develops innovative, sustained-delivery therapeutics for retinal diseases.
United States of America
EYPT

Talk to a Data Expert

Have a question? We'll get back to you promptly.